Trials / Completed
CompletedNCT05771090
First Clinical Evaluation of a Novel Glucose Non-invasive Sensor Technology in Patients With Type 1 Diabetes
First Clinical Evaluation of a Novel Glucose Non-invasive Sensor Technology in Patients With Type 1 Diabetes: a Single-arm Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- DCB Research AG · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this clinical study is to find signal characteristics of VOCs detected by Sokru device during fasting, insulin injection and after glucose intake and to find the association with blood glucose variation in variant states of glycemia and hypoglycemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Sokru device | Different induced glycaemic states in people living with diabetes (PwD). |
Timeline
- Start date
- 2023-04-01
- Primary completion
- 2023-06-16
- Completion
- 2023-06-16
- First posted
- 2023-03-16
- Last updated
- 2023-06-29
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05771090. Inclusion in this directory is not an endorsement.